Eugia Pharma receives USFDA Approval for Icatibant Injection

This is the 166th ANDA out of Eugia Pharma Speciality Group facilities

Biocon Biologics gets EMA’s positive opinion for an ophthalmology product

Bayer partners with biotech firm on lipid nanoparticle delivery systems

Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.

Takeda pledges support to HAE patients through its ‘Sunrise patient support program’

Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support

Zydus receives final approval from the USFDA for Acetazolamide Tablets

Acetazolamide is used to treat glaucoma

LF is not a neglected disease but a priority disease for elimination: Dr. Mandaviya

Zydus receives tentative approval from USFDA for Levothyroxine Sodium for Injection

The drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara, India

DME market across 7MM set to reach $11.1 billion in 2031, forecasts GlobalData

Siemens Healthineers expands its offerings in India

Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite

Alembic Pharmaceuticals receives USFDA Final Approval for Chlorthalidone Tablets

Chlorthalidone Tablets USP, 25 mg and 50 mg, have an estimated market size of US $37 million for twelve months ending June, 2022 according to IQVIA